Recent Finacing
Recent Raise
Promedior is a clinical-stage biotech developing Pentraxin-2 biologic therapeutics (e.g., PRM-151, PRM-167) that modulate monocyte-derived cells to treat fibrosis and ocular neovascular diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
